ZAHRA: JOURNAL OF HEALTH AND MEDICAL RESEARCH
Vol. 2 No. 3 (2022): JULI

LEGALITAS PENGGUNAAN OBAT SEBAGAI TERAPI PENYEMBUHAN PENYAKIT YANG DISEBABKAN OLEH COVID-19 DI MASA PANDEMI; STUDI TERHADAP PENGGUNAAN INVERMECTIN

Gunawan Widjaja (Universitas Krisnadwipayana, Indonesia)
Annisa Purwo Hastuti (Universitas Krisnadwipayana, Indonesia)

Article Info

Publish Date
10 Aug 2022

Abstract

There is no denying that the Covid-19 outbreak has become one of the most frightening diseases. One of them is the large number of use of drugs that have not been through clinical trials. One of them is Ivermectin. This paper describes several things that need to be known until a drug can be circulated and the meaning of granting the distribution permit. The discussion shows that Ivermectin does have a marketing authorization, however, Ivermectin, in that distribution permit, has never been indicated for the treatment of diseases as a result of Covid-19. The distribution permit must also be accompanied by Good Manufacturing Practices (GMP) and circulated in Good Drug Distribution Methods (CDOB).

Copyrights © 2022




Citation Download
RIS
EndNote, Reference Manager, ProCite
BibTex
Latex, Jabref
Full PDF
786.538 KB
Original Source
Download Original
Google Scholar
Check in Google Scholar
Journal Info
ZAHRA: JOURNAL OF HEALTH AND MEDICAL RESEARCH
Website

Abbrev

aisha

Publisher

CV. Adiba Aisha Amira

Subject

Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Description

This Journal focuses on health sciences, including preventive, promotive, curative, and rehabilitative fields, by publishing "original articles" and "review articles." The scientific scope of the Health Scientific Journal include Medical and clinical research, Public health research (health ...